Rasagiline for the treatment of parkinsonism in Huntington's disease
Autor*in: |
Pérez-Pérez, Jesús [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2015 |
---|
Schlagwörter: |
---|
Umfang: |
3 |
---|
Übergeordnetes Werk: |
Enthalten in: Parkinsonism & related disorders - Aral, Efecan ELSEVIER, 2022, official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:21 ; year:2015 ; number:3 ; pages:340-342 ; extent:3 |
Links: |
---|
DOI / URN: |
10.1016/j.parkreldis.2015.01.002 |
---|
Katalog-ID: |
ELV029253128 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV029253128 | ||
003 | DE-627 | ||
005 | 20230623195913.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2015 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.parkreldis.2015.01.002 |2 doi | |
028 | 5 | 2 | |a GBVA2015019000013.pica |
035 | |a (DE-627)ELV029253128 | ||
035 | |a (ELSEVIER)S1353-8020(15)00006-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 42.13 |2 bkl | ||
084 | |a 44.33 |2 bkl | ||
100 | 1 | |a Pérez-Pérez, Jesús |e verfasserin |4 aut | |
245 | 1 | 0 | |a Rasagiline for the treatment of parkinsonism in Huntington's disease |
264 | 1 | |c 2015 | |
300 | |a 3 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
650 | 7 | |a Parkinsonism |2 Elsevier | |
650 | 7 | |a Apathy |2 Elsevier | |
650 | 7 | |a Rasagiline |2 Elsevier | |
650 | 7 | |a Neuropsychiatric |2 Elsevier | |
650 | 7 | |a Huntington's disease |2 Elsevier | |
700 | 1 | |a Martínez-Horta, Saül |4 oth | |
700 | 1 | |a Pagonabarraga, Javier |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Aral, Efecan ELSEVIER |t Parkinsonism & related disorders |d 2022 |d official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders |g Amsterdam [u.a.] |w (DE-627)ELV009218491 |
773 | 1 | 8 | |g volume:21 |g year:2015 |g number:3 |g pages:340-342 |g extent:3 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.parkreldis.2015.01.002 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 42.13 |j Molekularbiologie |q VZ |
936 | b | k | |a 44.33 |j Physiologische Chemie |q VZ |
951 | |a AR | ||
952 | |d 21 |j 2015 |e 3 |h 340-342 |g 3 | ||
953 | |2 045F |a 610 |
author_variant |
j p p jpp |
---|---|
matchkey_str |
prezprezjessmartnezhortasalpagonabarraga:2015----:aaiieoteramnoprisnsih |
hierarchy_sort_str |
2015 |
bklnumber |
42.13 44.33 |
publishDate |
2015 |
allfields |
10.1016/j.parkreldis.2015.01.002 doi GBVA2015019000013.pica (DE-627)ELV029253128 (ELSEVIER)S1353-8020(15)00006-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 42.13 bkl 44.33 bkl Pérez-Pérez, Jesús verfasserin aut Rasagiline for the treatment of parkinsonism in Huntington's disease 2015 3 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Parkinsonism Elsevier Apathy Elsevier Rasagiline Elsevier Neuropsychiatric Elsevier Huntington's disease Elsevier Martínez-Horta, Saül oth Pagonabarraga, Javier oth Enthalten in Elsevier Science Aral, Efecan ELSEVIER Parkinsonism & related disorders 2022 official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders Amsterdam [u.a.] (DE-627)ELV009218491 volume:21 year:2015 number:3 pages:340-342 extent:3 https://doi.org/10.1016/j.parkreldis.2015.01.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 21 2015 3 340-342 3 045F 610 |
spelling |
10.1016/j.parkreldis.2015.01.002 doi GBVA2015019000013.pica (DE-627)ELV029253128 (ELSEVIER)S1353-8020(15)00006-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 42.13 bkl 44.33 bkl Pérez-Pérez, Jesús verfasserin aut Rasagiline for the treatment of parkinsonism in Huntington's disease 2015 3 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Parkinsonism Elsevier Apathy Elsevier Rasagiline Elsevier Neuropsychiatric Elsevier Huntington's disease Elsevier Martínez-Horta, Saül oth Pagonabarraga, Javier oth Enthalten in Elsevier Science Aral, Efecan ELSEVIER Parkinsonism & related disorders 2022 official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders Amsterdam [u.a.] (DE-627)ELV009218491 volume:21 year:2015 number:3 pages:340-342 extent:3 https://doi.org/10.1016/j.parkreldis.2015.01.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 21 2015 3 340-342 3 045F 610 |
allfields_unstemmed |
10.1016/j.parkreldis.2015.01.002 doi GBVA2015019000013.pica (DE-627)ELV029253128 (ELSEVIER)S1353-8020(15)00006-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 42.13 bkl 44.33 bkl Pérez-Pérez, Jesús verfasserin aut Rasagiline for the treatment of parkinsonism in Huntington's disease 2015 3 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Parkinsonism Elsevier Apathy Elsevier Rasagiline Elsevier Neuropsychiatric Elsevier Huntington's disease Elsevier Martínez-Horta, Saül oth Pagonabarraga, Javier oth Enthalten in Elsevier Science Aral, Efecan ELSEVIER Parkinsonism & related disorders 2022 official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders Amsterdam [u.a.] (DE-627)ELV009218491 volume:21 year:2015 number:3 pages:340-342 extent:3 https://doi.org/10.1016/j.parkreldis.2015.01.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 21 2015 3 340-342 3 045F 610 |
allfieldsGer |
10.1016/j.parkreldis.2015.01.002 doi GBVA2015019000013.pica (DE-627)ELV029253128 (ELSEVIER)S1353-8020(15)00006-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 42.13 bkl 44.33 bkl Pérez-Pérez, Jesús verfasserin aut Rasagiline for the treatment of parkinsonism in Huntington's disease 2015 3 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Parkinsonism Elsevier Apathy Elsevier Rasagiline Elsevier Neuropsychiatric Elsevier Huntington's disease Elsevier Martínez-Horta, Saül oth Pagonabarraga, Javier oth Enthalten in Elsevier Science Aral, Efecan ELSEVIER Parkinsonism & related disorders 2022 official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders Amsterdam [u.a.] (DE-627)ELV009218491 volume:21 year:2015 number:3 pages:340-342 extent:3 https://doi.org/10.1016/j.parkreldis.2015.01.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 21 2015 3 340-342 3 045F 610 |
allfieldsSound |
10.1016/j.parkreldis.2015.01.002 doi GBVA2015019000013.pica (DE-627)ELV029253128 (ELSEVIER)S1353-8020(15)00006-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 42.13 bkl 44.33 bkl Pérez-Pérez, Jesús verfasserin aut Rasagiline for the treatment of parkinsonism in Huntington's disease 2015 3 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Parkinsonism Elsevier Apathy Elsevier Rasagiline Elsevier Neuropsychiatric Elsevier Huntington's disease Elsevier Martínez-Horta, Saül oth Pagonabarraga, Javier oth Enthalten in Elsevier Science Aral, Efecan ELSEVIER Parkinsonism & related disorders 2022 official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders Amsterdam [u.a.] (DE-627)ELV009218491 volume:21 year:2015 number:3 pages:340-342 extent:3 https://doi.org/10.1016/j.parkreldis.2015.01.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 42.13 Molekularbiologie VZ 44.33 Physiologische Chemie VZ AR 21 2015 3 340-342 3 045F 610 |
language |
English |
source |
Enthalten in Parkinsonism & related disorders Amsterdam [u.a.] volume:21 year:2015 number:3 pages:340-342 extent:3 |
sourceStr |
Enthalten in Parkinsonism & related disorders Amsterdam [u.a.] volume:21 year:2015 number:3 pages:340-342 extent:3 |
format_phy_str_mv |
Article |
bklname |
Molekularbiologie Physiologische Chemie |
institution |
findex.gbv.de |
topic_facet |
Parkinsonism Apathy Rasagiline Neuropsychiatric Huntington's disease |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Parkinsonism & related disorders |
authorswithroles_txt_mv |
Pérez-Pérez, Jesús @@aut@@ Martínez-Horta, Saül @@oth@@ Pagonabarraga, Javier @@oth@@ |
publishDateDaySort_date |
2015-01-01T00:00:00Z |
hierarchy_top_id |
ELV009218491 |
dewey-sort |
3610 |
id |
ELV029253128 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV029253128</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623195913.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.parkreldis.2015.01.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015019000013.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV029253128</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1353-8020(15)00006-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.33</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pérez-Pérez, Jesús</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Rasagiline for the treatment of parkinsonism in Huntington's disease</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">3</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Parkinsonism</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Apathy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Rasagiline</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neuropsychiatric</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Huntington's disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Martínez-Horta, Saül</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pagonabarraga, Javier</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Aral, Efecan ELSEVIER</subfield><subfield code="t">Parkinsonism & related disorders</subfield><subfield code="d">2022</subfield><subfield code="d">official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV009218491</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:21</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:340-342</subfield><subfield code="g">extent:3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.parkreldis.2015.01.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.13</subfield><subfield code="j">Molekularbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.33</subfield><subfield code="j">Physiologische Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">21</subfield><subfield code="j">2015</subfield><subfield code="e">3</subfield><subfield code="h">340-342</subfield><subfield code="g">3</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Pérez-Pérez, Jesús |
spellingShingle |
Pérez-Pérez, Jesús ddc 610 bkl 42.13 bkl 44.33 Elsevier Parkinsonism Elsevier Apathy Elsevier Rasagiline Elsevier Neuropsychiatric Elsevier Huntington's disease Rasagiline for the treatment of parkinsonism in Huntington's disease |
authorStr |
Pérez-Pérez, Jesús |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV009218491 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 610 VZ 42.13 bkl 44.33 bkl Rasagiline for the treatment of parkinsonism in Huntington's disease Parkinsonism Elsevier Apathy Elsevier Rasagiline Elsevier Neuropsychiatric Elsevier Huntington's disease Elsevier |
topic |
ddc 610 bkl 42.13 bkl 44.33 Elsevier Parkinsonism Elsevier Apathy Elsevier Rasagiline Elsevier Neuropsychiatric Elsevier Huntington's disease |
topic_unstemmed |
ddc 610 bkl 42.13 bkl 44.33 Elsevier Parkinsonism Elsevier Apathy Elsevier Rasagiline Elsevier Neuropsychiatric Elsevier Huntington's disease |
topic_browse |
ddc 610 bkl 42.13 bkl 44.33 Elsevier Parkinsonism Elsevier Apathy Elsevier Rasagiline Elsevier Neuropsychiatric Elsevier Huntington's disease |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
s m h smh j p jp |
hierarchy_parent_title |
Parkinsonism & related disorders |
hierarchy_parent_id |
ELV009218491 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Parkinsonism & related disorders |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV009218491 |
title |
Rasagiline for the treatment of parkinsonism in Huntington's disease |
ctrlnum |
(DE-627)ELV029253128 (ELSEVIER)S1353-8020(15)00006-1 |
title_full |
Rasagiline for the treatment of parkinsonism in Huntington's disease |
author_sort |
Pérez-Pérez, Jesús |
journal |
Parkinsonism & related disorders |
journalStr |
Parkinsonism & related disorders |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2015 |
contenttype_str_mv |
zzz |
container_start_page |
340 |
author_browse |
Pérez-Pérez, Jesús |
container_volume |
21 |
physical |
3 |
class |
610 610 DE-600 610 VZ 42.13 bkl 44.33 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Pérez-Pérez, Jesús |
doi_str_mv |
10.1016/j.parkreldis.2015.01.002 |
dewey-full |
610 |
title_sort |
rasagiline for the treatment of parkinsonism in huntington's disease |
title_auth |
Rasagiline for the treatment of parkinsonism in Huntington's disease |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
container_issue |
3 |
title_short |
Rasagiline for the treatment of parkinsonism in Huntington's disease |
url |
https://doi.org/10.1016/j.parkreldis.2015.01.002 |
remote_bool |
true |
author2 |
Martínez-Horta, Saül Pagonabarraga, Javier |
author2Str |
Martínez-Horta, Saül Pagonabarraga, Javier |
ppnlink |
ELV009218491 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth |
doi_str |
10.1016/j.parkreldis.2015.01.002 |
up_date |
2024-07-06T20:57:31.072Z |
_version_ |
1803864717209370624 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV029253128</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623195913.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.parkreldis.2015.01.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2015019000013.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV029253128</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1353-8020(15)00006-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">42.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.33</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Pérez-Pérez, Jesús</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Rasagiline for the treatment of parkinsonism in Huntington's disease</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">3</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Parkinsonism</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Apathy</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Rasagiline</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neuropsychiatric</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Huntington's disease</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Martínez-Horta, Saül</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pagonabarraga, Javier</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Aral, Efecan ELSEVIER</subfield><subfield code="t">Parkinsonism & related disorders</subfield><subfield code="d">2022</subfield><subfield code="d">official journal of the World Federation of Neurology Research Committee on Parkinsonism and Related Disorders</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV009218491</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:21</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:3</subfield><subfield code="g">pages:340-342</subfield><subfield code="g">extent:3</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.parkreldis.2015.01.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">42.13</subfield><subfield code="j">Molekularbiologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.33</subfield><subfield code="j">Physiologische Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">21</subfield><subfield code="j">2015</subfield><subfield code="e">3</subfield><subfield code="h">340-342</subfield><subfield code="g">3</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.402793 |